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Highlights 31 
 32 
 LNS and CSB products with different milk-quantity and soy-quality are equally well accepted on 33 
organoleptic parameters  34 
 CSB was not consumed as readily as LNS 35 
 Both CSB and LNS products were perceived as easy to administer  36 
 Similar CSB and LNS products used in the study location  were perceived as beneficial to child health   37 
 LNS were to a higher degree associated with medicine or foods with medicinal properties 38 
 39 
 40 
Abstract 41 
The objective of this study was to evaluate the acceptability of new formulations of six corn-soy blended 42 
flours (CSB) and six lipid-based nutrient supplements (LNS) with different quantities of milk and qualities of 43 
soy to be used for the treatment of moderate acute malnutrition (MAM). Furthermore, we wanted to 44 
explore the acceptability of foods currently used for the prevention and treatment of malnutrition in Burkina 45 
Faso to identify possible barriers that could affect the acceptability of the new formulations of 46 
supplementary foods. The study was carried out prior to a randomized controlled trial evaluating the 47 
effectiveness of these new formulations.  48 
 49 
The study involved an observed test-meal and a three-day take-home ration of the experimental food 50 
supplements to 6-30-months-old healthy children, followed by questionnaire-based interviews about the 51 
acceptability of these supplements. Interviews and focus group discussions were carried out to explore the 52 
acceptability of foods currently used for the prevention and treatment of malnutrition.  53 
 54 
The results suggest that both LNS and CSB products with different quantities of milk and qualities of soy are 55 
equally well accepted among healthy children in rural Burkina Faso based on general appreciation of the 56 
supplements and organoleptic properties. All experimental foods received good ratings and there was no 57 
significant difference between the foods. However, after the take-home ration, 58% of participants receiving 58 
CSB reported having left-overs at the end of the day compared to 37% (n=33) of the participants receiving 59 
LNS (p=0.004), suggesting that CSB was not as readily consumed as LNS.  Yet, both CSB and LNS products 60 
were perceived as easy to administer and the frequency of feeding was estimated to be adequate. The study 61 
also found that similar foods, used for the prevention and treatment of malnutrition, were well appreciated 62 
in the study location. LNS were to a higher degree associated with medicine or foods with medicinal 63 
properties, but both LNS and CSB were perceived as beneficial to child health.   64 
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Introduction1 69 
Moderate acute malnutrition (MAM) affects 33 million  children worldwide and is a major global health 70 
problem as it results in increased morbidity and mortality and delayed cognitive development(M. M. Black 71 
et al., 2008; Black et al., 2013; R. E. Black et al., 2008). Yet, there is presently no consensus on 72 
supplementary foods for the management of MAM. According to the World Health Organization, (WHO), 73 
who are currently reviewing their guidelines, more evidence is needed before clear guidelines can be 74 
developed (World Health Organization, 2012).  75 
In recent years different approaches have been introduced for the management of MAM using fortified 76 
blended flours, such as enhanced versions of corn-soy blend (CSB) or lipid-based nutrient supplements 77 
(LNS) (Lazzerini et al., 2013). These supplementary foods vary in terms of cost, taste, texture, shelf life, how 78 
they are used as well as in nutritional composition. These are all factors that may affect the acceptability 79 
and thereby the beneficial effect of a nutritional intervention. Acceptability refers to how foods are 80 
perceived and acknowledged in terms of recommended quantity consumed, the perceived benefits and/or 81 
undesirable effects, ease of use as well as organoleptic qualities of the foods based on test meals and/or 82 
take-home rations for a minimum of seven days as described in previous studies(Adu-Afarwuah et al., 2008; 83 
Bahwere et al., 2009; Rowe et al., 2008). 84 
Soy and milk are key ingredients in existing supplementary foods for children with MAM. Soy is used to 85 
obtain high levels of protein. Yet unrefined soy contains anti-nutrients and may produce flatulence and 86 
abdominal discomfort due to the fermentation of indigestible oligosaccharides. Consequently this may 87 
affect the acceptability (Suarez et al., 1999). As an alternative, soy isolate can be used. It has an increased 88 
protein content and an enhanced protein digestibility as well as less anti-nutrients and indigestible 89 
oligosaccharides (Björck et al., 1983). Milk may have a beneficial impact on growth (Grillenberger et al., 90 
2003; Hoppe et al., 2008), it contains high quality protein and may furthermore influence the acceptability, 91 
                                                          
1
 Abbreviations: 
MAM, moderate acute malnutrition; CSB, corn-soy blend; LNS, lipid-based nutrient supplement; WHO, World Health Organization;  
DS, dehulled soy; SI, soy isolate; DSM, dry-skimmed milk; MUAC, mid-upper arm circumference 
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as it provides a more sweet and creamy taste (Hoppe et al., 2008).  However, both soy isolate and milk are 92 
more expensive ingredients. 93 
Only a few studies have compared the acceptability of CSB vs LNS products and found them equally well 94 
accepted. However, LNS were less likely to be left-over (Flax et al., 2010) and CSB was more likely to be 95 
shared (Flax et al., 2010; Wang et al., 2013). Acceptability of soy vs. milk-based foods have so far also only 96 
been compared in a few studies, and only in LNS products, where both types of foods were reported to be 97 
well-accepted by the target population (Kuusipalo et al., 2006; Matilsky et al., 2009).  One study compared 98 
and assessed the acceptability of LNS products with and without milk and found that milk did not affect 99 
acceptability (Owino et al., 2014). This was also the case for a study on soy- and rice-based complementary 100 
foods with and without milk powder (Paul et al., 2008).  However, to our knowledge, no studies have 101 
assessed and compared the acceptability of CSB vs LNS products with different quantities of milk and 102 
different qualities of soy for the treatment of MAM.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 103 
Prior to a randomized controlled trial evaluating the cost-effectiveness of 12 different new formulations of 104 
CSB and LNS with different quantities of milk and soy qualities for the management of MAM 105 
(ISRCTN42569496 at http://www.controlled-trials.com), we conducted a study to evaluate the acceptability 106 
of these new formulations. Furthermore, we wanted to explore the acceptability of foods currently used in 107 
the study location for the prevention and treatment of malnutrition, to identify possible barriers that could 108 
affect the acceptability of the new formulations of supplementary foods.  109 
 110 
Methodology 111 
The study took place in the department of Gonponsom, Yako health district, Province du Passoré in 112 
northern Burkina Faso in January-February 2013. The prevalence of MAM and SAM in the area were 9% and 113 
1·4%,  respectively (“Ministere de la Santé, Burkina Faso, Direction de la Nutrition. Rapport Enquete 114 
Nutritionnelle Nationale,” 2013). Regular preventive food distributions by WFP for children 6-36 months-115 
old, with either CSB or ready-to-use foods, depending on availability, were carried out at the local health 116 
centres in relation to routine mother-child healthcare activities. A combination of quantitative and 117 
qualitative methods was applied to evaluate and compare the extent of acceptability of the new products 118 
(part I) and to capture the multitude of views on supplementary foods currently used for the prevention 119 
and treatment of malnutrition in the study location(part II). 120 
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Methodology Part I: Acceptability of the new supplementary foods 121 
1.1 Participants 122 
A convenience sample of 180 children aged 6-30 months who had initiated complementary feeding, and 123 
with mid-upper arm circumference (MUAC) >125 mm were identified by local community health workers. 124 
Exclusion criteria were children with moderate or severe acute malnutrition by MUAC, oedema, history of 125 
peanut allergy, or who had severe illness requiring hospitalisation or who were registered in a nutritional 126 
program. An informed consent form was signed or thumb printed by caretakers prior to participation. 127 
1.2 Design  128 
Children were randomised to one of the 12 different supplements, i.e. 15 children/group, according to a 129 
blocked randomisation list with varying block sizes using http://www.randomization.com. Each of the 12 130 
supplementary foods was masked with a one-letter code and participants and all members of the research 131 
team were blinded to the soy and milk content of the supplementary foods, but not to the main type of 132 
food (CSB or LNS).  133 
The study included an observed test meal (visit 1) and a three-day take-home test (visit 2) with one of the 134 
12 experimental supplementary foods per participant. Both visits included questionnaires evaluating the 135 
acceptability of the new foods in terms of organoleptic qualities and perceived ease of use as well as 136 
adherence to recommendations. The take-home ration was included, because it was assumed that 137 
acceptability could increase over time. Other studies have provided a take-home ration for minimum a 138 
week(Hess et al., 2011, Wang et al., 2013). However, in this study, children were not malnourished and a 139 
supplement high in calories, fat and protein for a longer period of time could potentially have adverse 140 
effects. Therefore, it was decided to limit the take-home ration to three days. 141 
1.3 Intervention 142 
The 12 supplementary foods included six CSB and six LNS products, with either dehulled soy (DS) or soy 143 
isolate (SI) and with 0%, 20% or 50% of total protein as dry skimmed milk (DSM). All products were 144 
manufactured by GC Rieber Compact A/S (Bergen, Norway) and had similar micronutrient content provided 145 
by a pre-mix of vitamins and minerals according to a WHO Technical Note on supplementary foods for the 146 
management of MAM (World Health Organization, 2012) (Table 1).  A daily ration of LNS (92 g) and CSB 147 
(120 g) provided 500 kcal per child. LNS products were packed in 92 grams foil sachets containing a daily 148 
ration and did not require any preparation prior to consumption. CSB products were packed in foil bags and 149 
required cooking to become an edible porridge. The home ration of three daily rations of 120 gram CSB per 150 
day was dosed and provided in neutral local plastic bags. Mothers were instructed to prepare the porridge 151 
with a CSB-water volume ratio of either 1:3 or 1:4, depending on the desired viscosity. It was advised to 152 
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serve the porridge in three meals per day, giving 40 gram of CSB (167 kcal) per meal. Individual dose cups 153 
(per meal) were provided to all participants receiving the CSB products.  154 
 155 
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Observed test meal (visit 1) 156 
Participants were offered either 40 g of one of the CSB products corresponding to 1/3 of the daily ration or 157 
1 sachet of the LNS products corresponding to a full daily ration. The ration was served by two health 158 
workers between 8 am and 12 pm. Caretakers and children were divided into groups, placed in a quiet 159 
area, and served one group at a time with a maximum of four children per group at a time. Children in the 160 
CSB groups were served first and caretakers were showed how to prepare the porridge hygienically. 161 
Caretakers were also instructed to wash their hands before feeding the child. All children were offered 162 
water during the meal and there were no restrictions on breastfeeding prior to or during the test. 163 
Breastfeeding 30 minutes prior to serving was registered.  164 
After 30 minutes of observed consumption, caretakers were asked to evaluate the supplementary foods in 165 
terms of child appreciation, general perception, taste, colour, odour and texture according to their child’s 166 
reaction and own perception, based on a 5-point hedonic scale, where 1=dislike very much, 2=dislike, 167 
3=neither like nor dislike, 4=like and 5=like very much. The scale was illustrated in a series of human face 168 
symbols with varying degrees of smile or discontent. This is a method previously used to measure food 169 
acceptability in illiterate populations (Cohuet et al., 2012; Hess et al., 2011). If children were not able to 170 
finish the ration within the 30 minutes, caretakers were asked to estimate the quantity of left-overs. 171 
Three day take-home test (visit2) 172 
After the observed test, participants were given a three-day ration to take home and asked to come back 173 
the following week to complete the final questionnaire, which included the same questions as in the 174 
observed test. Additionally questions related to acceptability and management of the supplementary foods 175 
were included. These questionnaires were developed together with an experienced local research assistant 176 
fluent in the local language, Mooré, and familiar with the local culture. She also assisted in training and 177 
supervision of the two health workers carrying out the serving and the questionnaires on all participants.  178 
 179 
Methodology Part II: Perceptions of foods currently used in the study location 180 
Individual interviews and focus group discussions (FGD) were carried out with caretakers of young children 181 
to explore the acceptability of foods currently used for the prevention and treatment of malnutrition in the 182 
study location.  183 
2.1 Participants 184 
Participants for this part of the study included both caretakers from the quantitative part of the study and 185 
other caretakers of young children. The majority of the participants had personal experience with foods 186 
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used for the prevention and treatment of malnutrition, having young children that had either been treated 187 
for malnutrition or had benefitted from the regular food distributions at the health centres. 188 
2.2 Design 189 
Purposive sampling was used to ensure that data was as diverse as possible in terms of age and number of 190 
children of the caretakers. The number of interviews/FGDs was based on the principle of data saturation, 191 
including new participants as long as new themes emerged. The aim was to achieve analytical 192 
generalization, so that the emerging information would be comprehensive, complete, saturated and would 193 
account for deviant cases. The interviews and FGDs were carried out in Mooré by two research assistants 194 
trained for the purpose by the first author and a phenomenological approach was applied as described by 195 
Kvale (Kvale, 1996). The interviews and FGDs took place at the health centre or in the village of the 196 
participants in a secluded area, and lasted between 20-45 minutes. All interviews and FGDs were carried 197 
out following a semi-structured interview guide using open-ended questions within topics related to the 198 
perception of treatment of malnutrition in the study location. The interview guide was carefully discussed 199 
and developed with the two research assistants prior to the study, to ensure semantic coherence and 200 
relevance to the context. All interviews and FGDs were recorded, transcribed and translated from Mooré to 201 
French by the two research assistants and from French to English by the first author.  202 
Data analysis 203 
Quantitative data were doubly entered into Epidata 3.1 Software (Epidata Association, Odense, Denmark) 204 
and analyzed using Stata 12 (StataCorp, College Station TX, USA). Baseline characteristics, performance and 205 
management results of questionnaires from the observed and take-home tests were analyzed using chi-206 
square tests, initially considering contingency tables including all 12 supplementary foods. In addition, 207 
pairwise comparisons for 2-by-2 tables were carried out separately within the CSB and LNS groups, 208 
respectively. In case comparisons within these two groups were non-significant, an overall comparison was 209 
made between CSB and LNS. Differences in frequency of feeding between CSB and LNS were analyzed using 210 
analysis of variance. Differences in ratings of the organoleptic acceptability between supplementary foods 211 
and visits were analyzed using linear mixed models including product-visit interactions as fixed effects and 212 
participant-specific random effects. Additionally, all models were adjusted for age and sex. Likelihood ratio 213 
tests were used to evaluate product-visit interactions and, if these were non-significant, separate product 214 
and visit effects were estimated. Bonferroni adjustment was applied whenever multiple p-values were 215 
considered in an analysis. A significance level of 0.05 was used. 216 
Interviews and FGD were analyzed applying qualitative content analysis as outlined by Graneheim and 217 
Lundman (2004). First, each interview and FGD was kept intact and read through several times to obtain a 218 
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general sense of the content, searching for common themes and identifying manifest and latent content. 219 
From the text, condensed meaning units or portions of the text that were connected to a central meaning 220 
were formed and coded for that specific meaning. For example, if caretakers were talking about the 221 
abilities of supplementary foods, the specific ability would be coded (i.e; foods provide health). These codes 222 
were then assimilated into categories (i.e; abilities of supplementary foods) and from these, themes 223 
emerged (i.e; perceptions of supplementary foods).  In line with Graneheim and Lundman, meaning units, 224 
codes and categories could fit into more than one theme. Finally, findings from each of the interviews/FGDs 225 
were compared with the aim of exploring similarities, differences and patterns. The analysis was carried out 226 
with a focus on the subject and the context and an emphasis on differences and similarities found in the 227 
data, which is characteristic for the direction of qualitative content analysis described by Graneheim and 228 
Lundman. This approach rests on the underlying assumption that "reality can be interpreted in many 229 
different ways and the understanding is dependent on subjective interpretation". Consequently, a certain 230 
degree of interpretation is involved in the analysis of data (Graneheim and Lundman, 2004). 231 
Ethical approval 232 
As part of a larger study, this study was approved by the Ethical Committee for Health Research in Burkina 233 
Faso (2012-8-059) and consultative approval was obtained from the Danish National Committee on 234 
Biomedical Research Ethics (1208204).  235 
Results  236 
Participants characteristics  237 
180 children and their caretakers were included in the study during a period of four weeks. Randomization 238 
resulted in baseline equivalence. The mean age of the children were 14 months (SD +5), 62% (n=112) were 239 
males and 95% (n=171) (95%CI: 92-98%) were breastfed at inclusion. 82% (n=146) were reported healthy at 240 
inclusion (95%CI: 76-87%), while 15% (n= 27) and 3% (n=6) reported having light or moderate illness 241 
respectively (95%CI: 10-20% and 0.7-6% respectively). All children except one completed both visits of the 242 
study (Table 2).  243 
For the qualitative part of the study, four FGDs and 11 individual interviews were carried out with a total of 244 
38 caretakers, who were all biological mothers of the children. The mean (SD+) age of the caretakers was 245 
29.1 years (SD+8.3), the mean quantity of children per caretaker was 3.6 (SD+1.9) and number of 246 
household members was 12.8 (SD+6.5). 84% (n=32) of the caretakers had no education, 11% (n=4) had 247 
attended primary school and 5% (n=2) had attended secondary school. 248 
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General appreciation and organoleptic qualities of the new formulations  249 
In Table 3 organoleptic ratings of all products are listed. In terms of caretaker’s general perception and the 250 
organoleptic attributes related to odor and color of the supplementary foods, results show mean ratings 251 
between 3.8 and 4.1.There was no difference between the supplements, neither in ratings, nor how they 252 
were rated  from visit 1 to visit 2. Similarly, no difference was found between the supplements in terms of 253 
rating of taste.  However, there was an increase in this rating from visit 1 to visit 2 (0.23, 95% CI: 0.11-0.35, 254 
p=<0.001), which was also seen in the mean rating of the child’s perceived appreciation of the supplements 255 
(0.18, 95%CI: 0.04-0.31, p=0.012). Ratings of texture changed from visit 1 to visit 2 (p= 0.01), however only 256 
for some of the products: For CSB DS 0% (1) ratings increased from visit 1 to visit 2, from 3.5 to 4.0 (95% 257 
CI:3.2-3.69 and 95%CI: 3.7-4.22, respectively, p= 0.012). For LNS SI 0% (10), the rating decreased from visit 258 
1 to visit 2. However this difference was not significant after Bonferroni adjustment (P=0.12).   259 
 260 
Observed test meal – consumption and leftovers  261 
After 30 minutes of consumption of the supplementary foods, 78% (n=137) of participants had leftovers, 262 
with no marked differences between the 12 groups (p=0.21). The total mean of participants breastfeeding 263 
their children prior to the test meal were 55% (n=92), and presented no clear difference between the 264 
products (p=0.58)  265 
52% (n=73) of participants estimated to have half of the ration left, while 32% (n=45) estimated having half 266 
of the meal left. No clear differences between the 12 supplementary foods were found (p=0.12), despite 267 
the fact that the ration of CSB (40 g/167 kcal) corresponded to 1/3 of a daily ration, while the ration of LNS 268 
(92 g/500 kcal) corresponded to a full daily ration.  Regardless of the large proportion of children having 269 
left-overs, 74% (n=133) of caretakers said that the quantity to consume was adequate, with no clear 270 
difference between the products (p=0.47). 271 
 272 
Take home test – consumption and leftovers  273 
The number of caretakers reporting left-overs during the take home test was different between the 12 274 
supplementary foods (p=0.037) and between the CSB and LNS products (p=0.004) (Table 4). In the LNS 275 
group, 37% (n=33) reported having left-overs at the end of the day, compared to 58% (n=52) of caretakers 276 
receiving CSB.  In the CSB groups, 46% (n=23) and 44% (n=22) of caretakers reported having less than half 277 
or half of the daily ration left, respectively vs 53% (n=17) and 34% (n=11) of caretakers in the LNS groups, 278 
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respectively. 10% (n=5) of caretakers in the CSB groups reported having more than half of the daily ration 279 
left at the end of the day vs 13% (n=4) in the LNS groups.  280 
Out of the 85 caretakers reporting left-overs, 51% (n=42) stated that another under 5-year-old child ate 281 
what was left. 27% (n=22) said that the remains were eaten by the mothers, 15% (n=12) said that it was 282 
eaten by an older child (> 5 years), while 7% (n=6) said that it was either thrown out or other.  283 
 284 
Administration of the supplementary foods 285 
The reported mean frequency of feeding during the take home test was higher for CSB, than for LNS (Table 286 
5). When asked how they perceived the number of times they had been feeding their children with the 287 
supplement per day, 83% (n=150) of caretakers said that it had been adequate, while 14% (n=25) thought 288 
that it had not been frequent enough. Only 2% (n=4) thought that it had been too much. There was no 289 
difference between the 12 supplementary foods (P=0.23). The majority of the caretakers (96%) said that 290 
the administration of the products was easy, and there was no difference in the perception of 291 
administration neither between each of the products nor between the CSB and LNS groups. In the CSB 292 
groups, 85% (n=74)  of caretakers reported that they preferred a less viscous porridge with a CSB:water-293 
ratio of 1:4, compared to 15% (n=13) who said the preferred a CSB:water-ration of 1:3.  294 
 295 
Symptoms of illness after consumption 296 
When asked if the child had been ill following consumption of the supplementary foods, 8% of all 297 
caretakers (n=15) reported illness, with no significant difference between the 12 supplementary foods 298 
(P=0.71). Of the reported illnesses 47% (n=7) was diarrhea, while 13% (n=2) and 7% (n=1) were vomiting 299 
and rash respectively. The remaining 33% (n=5) were reported as other symptoms. 300 
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Foods used for the treatment and prevention of malnutrition in view 301 
Foods used for the prevention and treatment of malnutrition in the study location included both LNS and 302 
CSB products depending on availability. LNS were used for the treatment of severe acute malnutrition, 303 
while both LNS and CSB were used for the treatment of MAM and regularly distributed during routine 304 
maternal and child healthcare services for the prevention of malnutrition. Both types of foods were 305 
perceived as different from traditional/local foods and referred to as “Yombdo” in Mooré which means 306 
“wrinkled skin”. This is also a word used to describe malnutrition; the largest ethnic group in the study 307 
setting, the Mossi people, is known to have a metaphoric and metonymic style of reasoning when defining 308 
and categorizing an illness. This way,  cause, effect and cure are often grouped together in concrete images,  309 
which is used as a way of conceptualizing an illness (Sjaak van der Geest and Meulenbroek, Adèle, 1993).  310 
There were different perceptions of CSB and LNS in terms of the origin of the foods and their respective 311 
abilities. Although the ingredients were recognizable and to a large extent familiar in the study location, 312 
interviewees emphasized that LNS products were different from local foods. Many believed that it came 313 
from the Western part of the world and this was associated with high effectiveness.  314 
 315 
“If it is this food [LNS], even only with two sachets, the child will be revitalized very fast, but 316 
with our local foods, even if you make” Tô” [local dish of staples] of millet for the child, you 317 
will not see the same results. So you cannot say that it is the same thing, it is not at all the 318 
same thing” 319 
    (20-year-old mother of one) 320 
 321 
“We think it [LNS] is peanut butter mixed with oil, but we still think it is the food of the white 322 
people” 323 
    (FGD village of Ounon) 324 
CSB products appeared to be more familiar to the caretakers, as the ingredients and the composition of the 325 
foods were perceived as similar to local foods and many caretakers thought that CSB could be produced 326 
locally. Nevertheless, they believed that the preparation was different and that external aid had been used 327 
to refine the foods so that they could be beneficial to the health of the children. 328 
 329 
“The appearance is a mix of cereals, so this mix must be a combination that tries to improve 330 
the health of children…… I don't know how they make it but I think that it [CSB] is based on 331 
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our local foods. I think that the composition of the foods includes some of our local crops, and 332 
then they have improved it so that it is good for children” 333 
     334 
(48-year-old mother of six) 335 
 336 
 “You can find healthy foods here but it depends on how you combine it. The white people can 337 
transform millet to other things which we cannot. Perhaps the basic building blocks are here, 338 
but they have their way of preparing it [CSB].  Based on our crops, they are able to make 339 
beans, peanut, with lots of vitamins, but we do not know how to do that. Only they know 340 
what they are doing and then they send it to us” 341 
(40-year-old mother of seven) 342 
 343 
 “Yes it is possible [that CSB can be produced here], the flour used looks like maize flour” 344 
     (FGD village of Ounon) 345 
 346 
The perceived abilities of the products also differed. While the LNS products were strongly associated with 347 
medicine or perceived as having medicinal properties, no such associations were made for CSB at any point. 348 
Some caretakers perceived LNS as being medicine while others perceived them as being foods to improve 349 
the child’s condition during illness. Finally, some caretakers perceived LNS as being both foods and 350 
medicine.  351 
 352 
“…. we believe that it [LNS] is a drug, a drug that helps children very much…. This is the drug 353 
that saved my child when he was sick” 354 
(40-year-old mother of six) 355 
  356 
“It [LNS] ensures an improvement of his [the child’s] condition… this is because it is food”  357 
    (30-year-old mother of four) 358 
 359 
“I believe that it [LNS] is both, a drug and food to treat children with malnutrition” 360 
   (18-year-old mother of one) 361 
 362 
Overall there was a perception that foods used for the prevention and treatment of malnutrition were 363 
something that ensured the health of children.  364 
 We admire this food that treats our children….. it provides health  365 
(38-year-old mother of five) 366 
 367 
These foods are foods for the health 368 
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(48-year-old mother of six) 369 
 370 
Furthermore, there was a very strong confidence in the foods in terms of their abilities to provide health. 371 
The foods are powerful…… because when eating these foods, the child becomes healthy and 372 
strong in no time 373 
(FGD Ounon) 374 
 375 
This confidence seemed to be very fundamental. A mother whose child was having diarrhea after 376 
consuming LNS products replied the following after being asked if she continued to give the child the foods; 377 
“How can I do differently? This is what will make him recover” 378 
(18-year-old mother of one) 379 
 380 
 381 
Discussion  382 
The primary objective of this study was to evaluate the acceptability of 12 new formulations of 383 
supplementary foods for the treatment of MAM with different milk quantity and soy quality. Moreover, we 384 
wanted to explore the acceptability of foods currently used for the prevention and treatment of 385 
malnutrition in the study location to identify possible barriers for acceptability of new supplementary 386 
foods.   387 
All the new supplementary foods received high ratings in terms of caretakers’ appreciation, the perceived 388 
appreciation by the children and on organoleptic properties. There was no indication that the level of milk 389 
or the quality of soy had an impact on these parameters and overall there was little variability in the 390 
hedonic ratings. However, this result may not necessarily be conclusive as participants may have been 391 
reluctant to give poor ratings, as suggested in other studies (Adu-Afarwuah et al., 2011; Young et al., 2010). 392 
Yet, interestingly, ratings increased on certain parameters after the supplementary foods had been tested 393 
at home. Children’s food preferences are shaped by their early experience, and repeated exposure to foods 394 
in a safe and supportive environment increases food preference and acceptance (Birch and Marlin, 1982; 395 
Ventura and Worobey, 2013). The fact that the children were exposed to the supplementary foods more 396 
than once and that they were fed in their home environment may have increased the acceptability of the 397 
foods after the first visit, although the duration of home-feeding was shorter compared to other studies. 398 
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Acceptability of foods in terms of organoleptic preferences is difficult to assess in small children: study 399 
findings often reflects the taste and food preferences of the caretakers, which may be different from those 400 
of the child and which may not even reflect the real opinion, if participants engage in socially desirable 401 
responding. Therefore looking at the quantity of left-over may be a useful indicator of acceptability (Adu-402 
Afarwuah et al., 2011; Flax et al., 2010; Owino et al., 2014).  403 
In this study, the majority of caretakers estimated to have half or less of the ration served left following the 404 
observed test meal in all groups. In other studies, it has been suggested that acceptability is reached if  50-405 
75% of the meal is consumed (Adu-Afarwuah et al., 2011; Owino et al., 2014). However, as leftovers in this 406 
study were based on caretakers’ estimation, it may be difficult to compare these findings with other 407 
studies, where leftovers have been weighed and calculated by observers(Adu-Afarwuah et al., 2011,Hess et 408 
al., 2011). Yet, it is unexpected that the proportion of participants having leftovers was similar in all groups 409 
due to the difference in ration served: In the LNS groups a full daily ration of LNS was served (92 g), while in 410 
the CSB groups, the meal was rationed into single meals (40 g). It would therefore have been more likely 411 
that participants in the LNS groups had leftovers, as they were served a full day’s ration in a single meal as 412 
oppose to participants in the CSB groups who were served 1/3 of a full days ration. Additionally, more 413 
participants in the CSB groups reported left-overs, after having tested the supplementary foods for three 414 
days at home, compared to participants in the LNS groups. These findings suggest that the proposed single 415 
meal portion size and the recommended daily ration of CSB were difficult for small children to consume 416 
and therefore, that the CSB was not consumed as readily as the LNS . This is in line with a  previous study 417 
(Nackers et al., 2010) comparing the effectiveness of traditional CSB with a therapeutic LNS product 418 
(Plumpy’Nut®, Nutriset). It should be noted that no restrictions on breastfeeding were given prior to eating 419 
the supplementary foods, which may have influenced the appetite of the children and their ability to 420 
consume the ration served. However, these foods are only supplements to the diet and in order not to 421 
interfere with current breastfeeding practices, normal breastfeeding practices were encouraged and no 422 
restrictions were made at any point during the study. 423 
The difference in leftovers between CSB and LNS is likely due to the fact, that CSB products are less energy-424 
dense and have high bulkiness and volume compared to the high energy dense and low volume LNS 425 
products (de Pee and Bloem, 2009). This means that children receiving CSB have to eat several times the 426 
mass of food as children treated with LNS (LaGrone et al., 2012). For this reason, smaller and more frequent 427 
meals are recommended for less energy-dense diets, in order not to exceed the gastric capacity of the 428 
children (Brown et al., 1995). In our study, the mean frequency of feeding for the CSB products was 2.8 429 
meals/day, providing 40 g of CSB per meal and an increase of recommended feeding frequency could be 430 
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considered. However, recommending higher frequency of feeding with CSB may be problematic since 431 
preparation of the porridge is time-consuming and requires material for cooking in contrast to LNS which 432 
can be eaten directly out of the package. Increasing the frequency of feeding for a longer period of time 433 
with meals that require a long preparation may not be sustainable and could influence the acceptability in a 434 
context where the working day of the caretaker of children is already overloaded and resources are sparse. 435 
Surprisingly, the majority of caretakers reported the administration of the supplementary foods to be easy, 436 
regardless of the type of product (> 98%) and despite the fact that the frequency of feeding was higher for 437 
CSB than for LNS. In addition the frequency of feeding was perceived as adequate (83%) and only 2% of 438 
caretakers said that it was too high. Yet, the duration of the take-home test was short compared to other 439 
studies and to the average treatment duration of MAM. Consequently, the administration of the 440 
supplementary foods may have been perceived less burdensome than if supplementation had continued 441 
for a longer period of time.  442 
The qualitative data suggests that similar foods used for the prevention and treatment of malnutrition were 443 
well appreciated in the study location, although especially LNS were considered different from local foods. 444 
LNS were associated with both medicine or with foods with medicinal properties while no such reference 445 
were made for CSB, although it was considered to have been refined and to be beneficial to child health.  446 
Other studies have shown that in Niger, LNS  were mainly considered as medicine (Cohuet et al., 2012), 447 
while in Malawi both CSB and LNS were considered as foods (Flax et al., 2009) as well as medical 448 
treatments (Matilsky et al., 2009). The perception of foods used for the prevention and treatment of 449 
malnutrition as having medicinal properties is likely to have an impact on the acceptability. It may confirm 450 
the condition of the child as being ill, which enhances the care and adherence to the treatment and can 451 
promote the good intentions of the mother to ensure the health of her child (Whyte et al., 2002). These are 452 
important factors that could contribute to the acceptability of the supplementary foods, but would need to 453 
be explored further.  454 
Both types of products were perceived as beneficial to child health and there was a high degree of 455 
confidence in the abilities of the foods, as they were referred to as “powerful” while others said that they 456 
made children “strong in no time”.  Whyte et al has suggested that the efficacy of medical treatments is 457 
much related to the provenance of the product (Whyte et al., 2002). The fact that the foods were perceived 458 
to be developed or refined by ”white people”, could have enhanced their perceived efficacy in this context, 459 
where there seemed to be a high confidence in western medicine. This may not be applicable to other 460 
contexts.  461 
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We believe that the findings from the qualitative part of the study supports and qualifies the findings from 462 
the quantitative part: The fact that similar foods currently used in the study location for the prevention and 463 
treatment of malnutrition were well appreciated and perceived as beneficial to child health, whether they 464 
were considered as medicine, foods with medicinal properties or just refined foods, could explain the high 465 
level of acceptability of the new formulations.  466 
Limitations 467 
Still, we also acknowledge the limitations of the study. The relatively small sample size could be a limitation 468 
inasmuch as only few differences were found to be significant. Thus, the study lacked power to produce but 469 
few claims for individual acceptability outcomes. A larger sample size may have enabled us to find more 470 
significant differences between products.Yet, it was sufficient to demonstrate an overall proof of concept.  471 
Another limitation is that the quantity of left-overs was estimated by the caretakers and not weighed and 472 
calculated by observers as has been done in other studies. For the qualitative part of the study, the 473 
duration of the interviews and FGDs were relatively short and time to create trust between participants and 474 
the interviewers was therefore limited. Furthermore, community-sensitisation and communication 475 
regarding the project had been on-going prior to the interviews/FGDs and the non-local research team had 476 
been introduced to the local community. This may have influenced participants to respond more positively. 477 
Also, the analysis of qualitative data usually involves some degree of interpretation, while the translation 478 
from Mooré to French to English may have involved some loss of meaning. Finally, the acceptability was 479 
evaluated in healthy children, although the supplementary foods are designed for the treatment of children 480 
with MAM. The appetite of malnourished children is often compromised, which influences consumption 481 
and thus the acceptability of foods.  482 
 483 
Conclusion 484 
Knowing that foods used for the treatment and prevention of malnutrition are nutritionally and 485 
scientifically correct is not enough. The way that they are perceived and accepted by beneficiary 486 
populations are important factors determining the beneficial effect of a nutritional intervention. The results 487 
from this study showed that LNS and CSB products with different quantities of milk and qualities of soy 488 
were equally well accepted among healthy children in rural Burkina Faso on organoleptic parameters. 489 
However, participants in the CSB groups were less likely to consume the proposed single meal portion size 490 
or finish their daily ration. This may be due to the nature of the products, being high bulkiness foods, but it 491 
suggests that CSB is not consumed as readily as LNS.  Although home testing of the products was shorter 492 
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compared to other studies, both CSB and LNS products were perceived as easy to administer and the 493 
frequency of feeding was estimated to be adequate. The study also found that foods, similar to the 494 
introduced new formulations, currently used for the prevention and treatment of malnutrition in the study 495 
location were well appreciated. LNS were to a higher degree associated with medicine or foods with 496 
medicinal properties, but both LNS and CSB were perceived as beneficial to child health. Further research is 497 
needed to explore the acceptability of new formulations of supplementary foods among children with 498 
MAM and to assess how the perception of foods used for the prevention and treatment of malnutrition as 499 
having medicinal qualities may affect acceptability.  500 
 501 
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 619 
Tables 620 
Table 1. Food composition table of the 12 experimental supplementary foods 
  
 
WHO Technical Note 
2012
23
 
CSB per 120 g
4
 LNS per 92 g 
Product Unit 1 2 3 4 5 6 7 8 9 10 11 12 
Energy  Kcal 500  500 kcal 500 kcal 
Fat  g 12.5-32.5  11,4 11,7 11,4 11,4 11,4 11,4 31,6 31,5 32,1 31,4 31,5 31,4 
Protein  g 10-21.5  16,8 16,5 16,5 15,9 16,2 16,5 13,5 13,5 13,1 12,5 12,8 13,1 
Soy quality
5
    Flour Flour Flour Isolate Isolate Isolate Flour Flour Flour Isolate Isolate Isolate 
DSM
6
  %   0 8 20 0 8 20 0 8 20 0 8 20 
Calcium  mg 500-700  600 600  
Iron  mg 9
7
 -15
8
  12  12 
Magnesium  mg 140-210  175  175  
Phosporus
9
  mg 425-700  563  563  
Potassium  mg 750-1100  925  925  
Sodium  mg max 250  <250  <250  
Zinc  mg 10-17.5 14  14  
Copper  mg 0.5-1.8  1.15  1.15  
Manganese  mg 0.5-1.0  0.75  0.75 
Selenium  µg 17.5-45  31.5  31.5  
Iodine  µg 75-175  125  125  
Vitamin C  mg > 75  188  94  
Thiamin B1 mg  > 0.5  1.0 0.65  
Riboflavin B2 mg > 2.0 3.0 2.5  
Niacin  mg > 12.5 20.2 15.5  
Pantothenic 
acid  mg > 2.5  4.5 3.2  
Vitamin B6 mg >  1.8 1.25 
Folic acid  µg > 200 300 250  
Biotin  µg > 10  13.8 12.5  
                                                          
2
 The specifications are calculated as an example when food supplements provide 70% of energy. Note. This is not a recommendation that food 
supplements should constitute 70% energy intake of MM children. The formulation is such that it would be safe and effective if the quantity taken 
by MM children represented 100% energy needs and it would also provide benefit, though of a lesser order of magnitude, if taken in lower 
quantities(World Health Organization, 2012) 
3
 The energy density of food supplements when they are ready to be consumed (i.e. cooked foods ready for consumption or ready-to-use foods)  
should be not less than 0.8 kcal/g(World Health Organization, 2012) 
4 Some of the water soluble vitamins have been overdosed, in order to compensate for the degraded vitamins during preparation of CSB (GC Rieber 
Compact A/S)  
5 Flour = Dehulled soya flour; Isolate = Soy protein isolate 
6
 Percentage of total weight 
7
 assuming a 10 % bioavailability(World Health Organization, 2012) 
8
 assuming a 5% bioavailability(World Health Organization, 2012) 
9
 excluding Phosphorus from phytate because it is not bioavailable(World Health Organization, 2012) 
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Vitamin B 12  µg  2.5  4.1 3.15  
Retinol  µg 1000 - 1500 1375 1250  
Vitamin E  mg > 15  22.8 19  
Vitamin D  µg 10-30  22.0 20  
Vitamin K  µg  25  34.7 31.5 
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 621 
622 
                                                          
10 Missing data on one participant in the CSB SI 0%-group 
 
Table 2. Baseline characteristics among 180 children       
Product CSB LNS 
Soy quality Dehulled Soy Soy Isolate Dehulled Soy Soy Isolate 
DSM % 0% 
(1) 
20% 
(2) 
50% 
(3) 
0% 
(4) 
20% 
(5) 
50% 
(6) 
0% 
(7) 
20% 
(8) 
50% 
(9) 
0% 
(10) 
20% 
(11) 
50% 
(12) 
Participants 15 15 15 15 15 15 15 15 15 15 15 15 
Age (months) mean (+SD) 13 +5 15 +5 12 +6 14 +6 15 +7 15 +5 15 +5 14 +5 13 +5 15 +6 16 +5 12 +5 
Males % (n)  73(11) 53(8) 40(6) 67(10) 73(11) 80(12) 67(10) 60(9) 40(6) 80 (12) 47(7) 67(10) 
Breastfeeding % (n)  100(15) 100(15) 100(15) 93(14) 93(14) 100(15) 93(14) 87 (13) 93(14) 100(15) 80(12) 100(15) 
             
Health status at inclusion
10
                         
Healthy % (n) 86(13) 86(13) 87(13) 79(11) 66(10) 93(14) 80(12) 73(11) 73(11) 80(12) 93(14) 80(12) 
Light illness, no medication % (n) 7(1) 7(1) 13(2) 7(1) 27(4) 7(1) 20(3) 27(4) 20(3) 20(3) 7(1) 20(3) 
Moderate illness, medication but no 
hospitalization  % (n) 
7(1) 7(1) 0 14(2) 7(1) 0 0 0 7(1) 0 0 0 
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Table 3. Estimated mean perception (scale from 1 to 5
11
) of the 12 experimental foods at two visits 
Product   CSB LNS 
 
Mean 
per 
visit 
 
95% CI   P-values   
Soy quality 
 
Dehulled Soy Soy Isolate Dehulled Soy Soy Isolate 
 product-visit 
interaction 
product main 
effect 
visit main 
effect 
DSM (%) 
  
0% 
(1) 
20% 
(2) 
50% 
(3) 
0% 
(4) 
20% 
(5) 
50% 
(6) 
0% 
(7) 
20% 
(8) 
50% 
(9) 
0% 
(10) 
20% 
(11) 
50% 
(12) 
 
Child's 
appreciation 
Visit 1 3.7 3.8 3.7 4.1 4.0 4.1 3.6 4.1 4.1 4.3 4.1 4.1 4.0 [3.9-4.1] 
0.63 0.24 0.012 
Visit 2 4.1 4.3 4.1 4.1 4.2 4.3 4.0 3.9 4.3 4.1 4.3 4.2 4.2 [3.9-4.4] 
General 
perception 
Visit 1  4.1 3.9 4.1 4.2 4.1 4.0 4.0 4.1 4.3 4.1 4.1 4.1 4.1 [3.9-4.2] 
0.4 0.11 0.66 
Visit 2 4.1 4.1 4.1 3.9 4.0 4.1 4.0 4.0 4.3 4.0 4.1 4.1 4.1 [4.0-4.1] 
Taste 
Visit 1 3.8 3.5 3.8 3.9 3.5 3.8 3.8 3.9 4.1 3.8 3.9 4.0 3.8 [3.7-3.9] 
0.48 0.23 <0.001 
Visit 2 4.1 4.1 4.0 4.2 4.0 3.8 3.9 3.9 4.1 4.0 4.3 4.1 4.0 [3.8-4.3] 
Odor 
Visit 1  4.0 3.7 3.9 3.7 4.0 4.1 3.9 3.9 3.9 3.9 4.0 4.0 3.9 [3.9-4.0] 
0.68 0.86 0.8 
Visit 2 4.0 4.0 3.9 3.9 3.9 3.9 4.0 3.9 3.9 3.8 3.8 3.9 3.9 [3.8-4.1] 
Colour 
Visit 1  4.2 4.1 4.1 4.1 3.8 4.1 3.9 4.0 4.2 4.0 4.1 3.9 4.0 [4.0-4.1] 
0.66 0.27 0.09 
Visit 2 4.0 4.0 4.0 4.0 4.0 4.0 4.0 3.9 4.0 3.9 4.0 3.8 4.0 [3.9-4.1] 
Texture 
Visit 1 3.5 3.6 3.9 3.9 3.9 3.7 3.7 3.7 3.9 4.1 3.8 3.6 3.8 [3.7-3.8] 
0.01 
 
  
 
 
  
 
Visit 2 4 4 3.9 4 4 4 3.9 3.7 3.9 3.7 4 3.8 3.9 [3.8-4.1] 
 623 
                                                          
11
 Organoleptic ratings on a 5 point hedonic scale where 1=dislike very much, 2= dislike, 3=neither like or dislike, 4 =like, 5= like very much 
 Evaluation of differences between combinations of product and visit effects by means of linear mixed models with adjustment for age and sex and differences 
between children (random effects) . 
 In case product-visit interaction is non-significant, evaluation of differences between products (also using linear mixed models) 
 In case product-visit interaction is non-significant, evaluation of differences between the two visits (also using linear mixed models). 
- -
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Table 4. Leftovers during take home test on 179 children 
Product   CSB LNS     
Soy quality 
 
Dehulled Soy Soy Isolate Dehulled Soy Soy Isolate 
  DSM % 
 
0% 20% 50% 0% 20% 50% 0% 20% 50% 0% 20% 50% Total P-value  
  
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) 
  Left-over at the end of 
the day  % (n) 67 (10) 53 (8) 64 (9) 60 (9) 47 (7) 60 (9) 67 (10) 27 (4) 47 (7) 40 (6) 13 (2) 27 (4) 48 (85) 0,037 
                    CSB vs LNS 
 
58 (52) 37 (33) 
 
0.004 
               
Quantity of left-over  
< than half 40 (4) 37.5 (3) 45 (4) 62.5 (5) 43 (3) 50 (4) 40 (4) 75 (3) 50 (3) 50 (3) 100 (2) 50 (2) 49 (40) 
0.84 half 50 (5) 37.5 (3) 33 (3) 37.5 (3) 57 (4) 50 (4) 30 (3) 25 (1) 50 (3) 33 (2) 0 50 (2) 40 (33) 
> than half 10 (1) 25 (2) 22 (2) 0 0 0 30 (3) 0 0 17 (1) 0 0 11 (9) 
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Table 5. Administration of products during take-home test on 179 children  
Product 
 
CSB LNS 
  
Frequency of feeding/day,  Mean (Std. Err) 2.8 (0.08) 2.3 (0.07) 
 
0.000 
Administration of the products % (n) 
difficult 1 (1) 0 0.6 (1) 
0.5 
indifferent 1 (1) 0 0.6 (1) 
easy 96 (84) 97 (85) 96 (169) 
very easy 2 (2) 3 (3) 2.8 (5) 
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